CookD, BrownD, AlexanderR, et al.Lessons learned from the fate of AstraZeneca's drug pipeline: A five-dimensional framework. Nat. Rev. Drug. Discov., 2014Jun; 13(6): 419–431. doi: 10.1038/nrd4309. Epub 2014May16.
2.
TuckerDF, SullivanJT, MattiaKA, et al.Isolation of state-dependent monoclonal antibodies against the 12-transmembrane-domain glucose transporter 4 using virus-like particles. Proc. Natl. Acad. Sci. USA, 2018May29; 115(22): E4990–E4999. doi: 10.1073/pnas.1716788115. Epub 2018May16.
3.
WilliamsGS, MistryB, GuillardS, et al.Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy. Oncotarget, 2016Oct18; 7(42): 68278–68291. doi: 10.18632/oncotarget.11943.
